Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Clin Genitourin Cancer. 2013 Jul 5;11(4):10.1016/j.clgc.2013.04.029. doi: 10.1016/j.clgc.2013.04.029

Table 1.

Patient Characteristics (n = 44)

Arm 1 (n = 14) Arm 2 (n = 15) Arm 3 (n = 15)
Mean (SD) age, years 67.1 ± 7.8 66.5 ± 8.5 64.4 ± 11.9
Race, no. patients
 African American 0 1 0
 White 13 13 15
 Unknown 1 1 0
Mean (SD) BSA, m2 2.18 ± 0.27 2.12 ± 0.18 2.14 ± 0.19
ECOG PS score
 0 11 13 12
 1 3 2 2
Clinical stage, no. patients
 D0 10 8 9
 D1 3 4 3
 D2 1 3 3
 LN mets 1 1 1
 Bone mets 0 2 3
Gleason score
 Unknown 1 1 1
 ≤6 5 4 1
 7 5 6 5
 8 0 2 4
 9 3 2 4
 10 0 0 0
Mean (SD) baseline T score
 Lumbar spine 1.06 ± 1.71 1.72 ± 1.85 0.77 ± 1.38
 Femoral neck −0.42 ± 1.94 −0.27 ± 1.11 −0.27 ± 1.14
 Total proximal femur 0.26 ± 1.61 0.36 ± 1.22 0.13 ± 0.85
 Trochanter 0.69 ± 1.95 0.83 ± 1.49 0.26 ± 1.22
Number of patients with low BMD at baseline
 Osteopenia (T score, 4 3 5
 −1.0 to −2.4)
 Osteoporosis (T score, less than or equal to −2.5) 2 1 0

Abbreviations: BMD = bone mineral density; BSA = body surface area; ECOG PS = Eastern Cooperative Oncology Group ECOG Performance Status; LN = lymph node.